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Abstract
In nocturnal rodents, brain areas that promote wakefulness have a circadian pattern of neural
activation that mirrors the sleep/wake cycle, with more neural activation during the active phase
than during the rest phase. To investigate whether differences in temporal patterns of neural
activity in wake-promoting regions contribute to differences in daily patterns of wakefulness
between nocturnal and diurnal species, we assessed Fos expression patterns in the
tuberomammillary (TMM), supramammillary (SUM), and raphe nuclei of male grass rats
maintained in a 12:12h light-dark cycle. Day-night profiles of Fos expression were observed in the
ventral and dorsal TMM, in the SUM, and in specific subpopulations of the raphe, including
serotonergic cells, with higher Fos expression during the day than during the night. Next, to
explore whether the cerebrospinal fluid is an avenue used by the TMM and raphe in the regulation
of target areas, we injected the retrograde tracer cholera toxin subunit beta (CTB) into the
ventricular system of male grass rats. While CTB labeling was scarce in the TMM and other
hypothalamic areas including the suprachiasmatic nucleus, which contains the main circadian
pacemaker, a dense cluster of CTB-positive neurons was evident in the caudal dorsal raphe, and
the majority of these neurons appeared to be serotonergic. Since these findings are in agreement
with reports for nocturnal rodents, our results suggest that the evolution of diurnality did not
involve a change in the overall distribution of neuronal connections between systems that support
wakefulness and their target areas, but produced a complete temporal reversal in the functioning of
those systems.
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Wakefulness is supported by several systems distributed throughout the mammalian brain,
including the serotonergic raphe and the histaminergic tuberomammillary nuclei (TMM;
reviewed in Jones, 2005). In nocturnal rodents these brain areas exhibit increased activation
during the active phase in comparison to the inactive phase of the animals' activity/rest cycle
(Guzman-Marin et al., 2000, Ko et al., 2003, Takahashi et al., 2006). Likewise, in the
diurnal grass rat, Arvicanthis niloticus, the ventral tuberomammillary nucleus (VTM)
exhibits a day-night difference in neural activation (as assessed by Fos expression) that
resembles the species daily activity/rest cycle (Novak et al., 2000), but that pattern has not
been documented for this rodent's dorsal tuberomammillary nucleus (DTM). Also, it
remains to be determined whether the raphe nuclei of diurnal species exhibit daily patterns
of neural activation and whether the phase of such rhythms differs between diurnal and
nocturnal animals. The implications of these observations are important for understanding
the differential roles that histaminergic and serotonergic brain areas have on the circadian
regulation of behavior in diurnal and nocturnal species.
Given that neural activity in histaminergic and serotonergic areas appears to be regulated by
circadian mechanisms, and that in other arousal systems increased neural activity is
accompanied by release of neurotransmitters at terminal buttons (Greco et al., 1999, Greco
et al., 2000), it is likely that the release of histamine (HA) and serotonin (5HT) into target
areas also follows a circadian pattern. Of particular interest is the choroid plexus (CP) as a
possible target for circadian modulation by histaminergic and/or serotonergic inputs. The
CP, located at different sites of the third (3V), fourth (4V) and lateral ventricles (LV;
Wolburg and Paulus, 2010), is the site of production of the cerebrospinal fluid (CSF), which
transports essential molecules throughout the nervous system. The CP contains receptors for
5HT (Watson et al., 1995) and HA (Crook et al., 1986), and both neurotransmitters influence
metabolism in this area (Crook et al., 1984, Watson et al., 1995); the route may be through
their direct release into the CSF as suggested by studies that report the presence of
histaminergic (Ericson et al., 1987, Tillet et al., 1998) and serotonergic (Lorez and Richards,
1973, Chan-Palay, 1976) axons or dendrites in close proximity to the ventricles.
Here we examine the hypothesis that differences in temporal patterns of neural activity in
histaminergic and serotonergic areas could contribute to differences in daily patterns of
arousal between nocturnal and diurnal species. To this end, we used Fos expression to
examine functional changes in cells of the DTM, VTM, and dorsal (DR) and median (MR)
raphe nuclei of male grass rats across the 24 h day. All of these regions not only support
wakefulness, but also have been implicated in the modulation of circadian entrainment
(Meyer-Bernstein and Morin, 1999, Harrington et al., 2000). We also measured Fos
expression in the supramammillary nucleus (SUM) because of its role in arousal and reward
(reviewed in Pan and McNaughton, 2004, Ikemoto, 2010). Additionally, to examine whether
serotonergic and histaminergic areas of the grass rat brain have access to the CSF, we
injected the retrograde tracer cholera toxin subunit beta (CTB) into the 3V or LV and
examined the pertinent areas for the presence of CTB labeled neurons. In the DR we
combined the analysis of CTB with identification of 5HT-positive neurons.
2. Experimental procedures
Adult male grass rats, born in our laboratory and derived from a group brought from Kenya
(Katona and Smale, 1997), were used in this study. Animals were kept on a 12:12h light-
dark cycle [lights on at zeitgeber time (ZT) 0] and provided with ad libitum access to water
and food. All experiments were approved by the Michigan State University Institutional
Animal Care and Use Committee in compliance with guidelines established by that
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institution as well as the National Institutes of Health Guide for the Care and Use of
Laboratory Animals.
2.1. Experiment 1: Neural activation in TMM, SUM and raphe
2.1.1. Immunocytochemistry (ICC)—Animals (n = 6 per ZT) were perfused at ZTs 2,
6, 10, 14, 18, and 22. Intraperitoneal injections of sodium pentobarbital (Ovation
Pharmaceutical, Deerfield, IL, USA) were used to deeply anesthetize the animals. To
prevent exposure to light, animals that were perfused during the dark phase were injected
under a red light (< 5 lux) and were fit with an aluminum foil hood upon anesthesia onset.
All animals were intracardially perfused with 0.9% saline, followed by 4% N-(3-
Dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (Sigma-Aldrich, St. Louis, MO,
USA) in 0.1 M phosphate buffer (PB; note that this step was called for by the HA antibody
used, AB5885; Millipore, Temecula, CA, USA), and then by 4% paraformaldehyde with 75
mM lysine and 10 mM sodium periodate (PLP) in 0.1 M PB. Following perfusion, brains
were removed, post-fixed for approximately 4 h in PLP, and transferred to 20% sucrose in
0.1 M PB at 4°C until they sunk to the base of the vial. Then, coronal sections (30 μm) were
cut on a freezing sliding microtome. Alternate sections were collected in three series in
cryoprotectant and stored at -20°C until further processing. One series was used for the
colocalization of Fos and 5HT and another for Fos and HA.
Since the ICC for Fos and HA did not produce adequate double labeling (data not shown),
we limited our study to the analysis of Fos expression in the TMM and SUM and of Fos and
5HT expression in the raphe. Unless indicated otherwise, all ICC procedures were carried
out at room temperature, and all incubations and rinses involved gentle agitation. In
addition, with the exception of experiment 2, sections were rinsed 3 times (5min/rinse) in
0.01 M phosphate buffered saline (PBS) between all ICC steps and all incubations included
0.3% Triton X-100 (TX) and PBS. For Fos staining, free-floating sections containing the
TMM, SUM, and raphe were washed in PBS (6 times, 10min/rinse), blocked (1 h) using 5%
normal donkey serum (NDS; 017-000-121; Jackson ImmunoResearch Laboratories, West
Grove, PA, USA), and incubated overnight in a rabbit anti-Fos antibody (1:20000 in 3%
NDS; SC-52; Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 4°C. Then, sections were
treated with a donkey anti-rabbit biotinylated antibody (1:200 in 3% NDS for 1 h;
711-065-152; Jackson ImmunoResearch Laboratories) and the avidin-biotin peroxidase
method (0.9% each avidin and biotin solutions for 1 h; PK-6100; Vector Laboratories,
Burlingame, CA, USA) with 0.025% diaminobenzidine enhanced with 2.5% nickel sulfate
as the chromogen. For 5HT staining, the same sections were blocked (1 h) in 5% normal
goat serum (NGS; S-1000; Vector Laboratories), incubated overnight in a rabbit anti-5HT
antibody (1:10000 in 3% NGS; NT-102; Protos Biotech Corp., New York, NY, USA) at 4°C
and treated with a goat anti-rabbit biotinylated antibody (1:200 in 3% NGS for 1 h;
BA-1000; Vector Laboratories), after which the avidin-biotin peroxidase method (0.9% each
avidin and biotin solutions for 1 h) was used with 0.02% diaminobenzidine as the
chromogen. All sections were mounted on slides, dehydrated, and coverslipped with DPX
mountant for histology (Sigma-Aldrich).
2.1.2. Quantification—For Fos quantification in the TMM, we selected one section that
contained both the VTM and DTM. For the quantification of Fos and 5HT expression in the
raphe, we selected three sections containing the medial subdivision of the dorsal raphe
(mDR), one containing the lateral subdivision of this nucleus (lDR), and one of the MR. In
addition, we quantified the expression of Fos in one section containing the SUM.
For the DTM, cells expressing Fos were counted within a region defined by a 120 μm2 box
placed on either side of the 3V; whereas for the VTM, we used a 150 μm2 box placed at the
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edge of the brain following the criteria used previously by our group (Novak et al., 2000).
For the lDR, the sampling region was defined by a 150 μm (width) × 650 μm (height) box
placed lateral to the mDR, immediately dorsal to the medial longitudinal fasciculus (Fig.
1A). For the mDR, the three sections analyzed corresponded to levels 3, 4, and 5 following
the nomenclature of Janusonis and colleagues (Janusonis et al., 1999), which in here we
refer to as mDR3, mDR4, and mDR5, respectively. Levels 1 and 2 were not analyzed
because Fos staining was rare in those regions (data not shown). The sampling boxes used
for mDR3 and mDR4 [150 μm (width) × 650 μm (height)] were placed at the midline,
medial to the dorsal borders of the medial longitudinal fasciculi (Fig. 1A and 1C). The
sampling box for mDR5 (160 μm2) was placed ventral to the 4V (Fig. 1E). For the MR, the
sampling region was defined by a box [(150 μm (width) × 700 μm (height)] placed on
midline in an area rich in 5HT staining (Fig. 1A). Finally, a 160 μm2 sampling box was
placed in the caudal SUM, as described previously (Castillo-Ruiz et al., 2010).
Counts were done bilaterally in the DTM, VTM, and lDR, and cell numbers for these areas
were averaged for each section. The mDR, MR, and SUM did not require this procedure
since these regions extended across the midline (see Fig. 1 and Castillo-Ruiz et al., 2010). In
addition, for the lDR and all levels of the mDR cell counts were divided by the area
occupied by their sampling box and the results are expressed as number of cells/mm2. This
procedure was necessary because for some sections part of the sampling boxes fell outside
the target areas. All counts were done using a 25× objective under a light microscope
equipped with a drawing tube (Laborlux 8, Leitz Wetzlar GBH, Wetzlar, Germany), and
performed by an investigator blind to the time of day at which the tissue was collected.
Data were analyzed with non-parametric methods, because of unequal variance.
Specifically, we used Kruskal-Wallis tests to assess the effects of sampling time on the
expression of Fos in serotonergic and non-serotonergic cells. Significant effects of sampling
time were followed by Mann-Whitney U tests. For all comparisons differences were
considered significant when p was less than 0.05 (two-tailed tests). The software used for
the statistical analyses was SPSS 17 (SPSS Inc., Chicago, IL, USA).
2.2. Experiment 2: Putative projections to the CSF
2.2.1. Surgical procedures—Grass rats were deeply anesthetized with isoflurane and
their heads were shaved, disinfected with povidone-iodine, and injected with lidocaine (6
mg/kg; s.c.; Hospira Inc., Lake Forest, Il, USA) and buprenorphine (0.05 mg/kg; s.c.;
PharmaForce, Inc., Hiliard, OH, USA). Then, animals were placed in a stereotaxic apparatus
(Stoelting Co., Wood Dale, Il, USA) with the incisor bar placed 6 mm below the center of
the ear bars for injections to the 3V and 4.5 mm below the center for injections to the LV. A
hamilton syringe (Hamilton Company, Reno, NV, USA), filled with CTB (10 mg/ml; 3V: 20
nanoliters, LV: 40 nanoliters; C9903; Sigma-Aldrich) was used to deliver the tracer. The
syringe was angled at 10 degrees for injections to the 3V and at 0 degrees for injections to
the LV. The coordinates to determine the injection site for the 3V were: AP (+ 1.4 mm), ML
(+ 1.3 mm, right), DV (- 6.2 mm), and for the LV: AP (+ 1.8 mm), ML (+ 0.5 mm, right),
DV (- 2.5 mm); the coordinates were determined with reference to bregma (AP and ML) and
dura (DV). The tracer was delivered over a 5 min interval and left in place for 5 min (LV
injections) or 15 min (3V injections). The incision was closed with autoclips, and treated
with novalsan antiseptic ointment (Fort Dodge Animal Health, Fort Dodge, IA, USA). To
prevent dehydration, all animals received 2 cc of sterile saline (s.c.). The animals were left
to recover on a heating pad, and received post-operatively either buprenorphine (0.05 mg/
kg; s.c.; every 12 h for the first day) and ketoprofen (5 mg/kg; s.c.; every 24 h for the
following two days; Fort Dodge Animal Health), or ketoprofen (5 mg/kg; s.c.; at the time of
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surgery) and meloxicam (0.2 mg/kg; orally; every 24 h for the following two days;
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO, USA).
2.2.2. Distribution of retrogradelly labeled cells—Seven days after CTB injections
(Mikkelsen et al., 1997), animals were given an overdose of sodium pentobarbital and
perfused transcardially during the light phase (between ZTs 2-7) with PBS, followed by
PLP. Brains were then post-fixed and sectioned following the procedure described above.
For injections to the 3V, the tissue was rinsed (6 times, 10 min/rinse) in 0.05 M tris-buffered
saline (TBS) in 0.04% TX, blocked (30 min) in 5% normal rabbit serum (S-5000; Vector
Laboratories) in 0.04% TX-TBS, and rinsed once in 0.04% TX-TBS. Then, sections were
incubated in a goat anti-CTB antibody (1:5000 in 0.04% TX-TBS; 703; List Biological
Laboratories, Inc., Campbell, CA, USA) for 60 h at 4°C. After this step, the tissue was
rinsed in 0.02% TX-TBS (5 min/rinse) and incubated in a rabbit anti-goat antibody (1:200 in
0.02% TX-TBS for 2 h; BA-5000; Vector Laboratories). Then, sections were rinsed in
0.02% TX-TBS (3 times, 5 min/rinse) and incubated in avidin-biotin peroxidase complex
(0.9% each avidin and biotin solutions in 0.02% TX-TBS for 2 h). After 3 rinses (5 min/
rinse) in 0.02% TX-TBS and one rinse (5 min) in TBS, the tissue was reacted in 0.01%
diaminobenzidine in 0.1 M PB and then rinsed in 0.1 M Tris buffer (4 times, 5 min/rinse).
For injections to the LV, the tissue was rinsed in PBS (6 times, 5 min/rinse) and then
incubated in 10% hydrogen peroxide in PBS for 20 min. After this step, we followed the
cytoplasmic staining protocol outlined above (section 2.1.1, for 5HT) using normal horse
serum (S-2000; Vector Laboratories), goat anti-CTB antibody (1:100000), and biotinylated
horse anti-goat as secondary antibody (1:200; BA-9500; Vector Laboratories). All sections
were mounted on slides, then dehydrated, coverslipped with DPX, and later examined using
a light microscope (Laborlux 8, Leitz Wetzlar GBH, Wetzlar, Germany and DM IRB Leica
Microsystems, Deerfield, IL, USA).
2.2.3. Distribution of cells labeled for CTB and 5HT—Since CTB cells were absent
in the VTM and rare in the DTM (see section 3.2.1), we limited our double-labeling analysis
to CTB and 5HT in mDR3 through mDR5, which were the only regions of the mDR
containing CTB-positive cells. Free-floating sections containing mDR3, mDR4, and mDR5
were blocked (30 min) in 5% NDS (Jackson ImmunoResearch Laboratories), after which
they were incubated in a rabbit anti-5HT antibody (1:1000; Protos Biotech) for 48 h at 4°C,
and treated with a Cy2 donkey anti-rabbit antibody (1:100 for 2 h; 711-225-152; Jackson
ImmunoResearch). Then, the tissue was incubated in a goat anti-CTB antibody (1:500; List
Biological Laboratories) for 48 h at 4°C and then treated with a Cy3 donkey anti-goat
antibody (1:100 for 2 h; 705-165-147; Jackson ImmunoResearch Laboratories). Between
steps, sections were rinsed several times in PBS with 0.1% TX, and all incubations included
PBS and 0.3% TX. Sections were mounted on slides, dehydrated, coverslipped with DPX,
and stored at 4°C. To examine colocalization of CTB and 5HT we used a fluorescent
microscope (Zeiss Axioscop 2 plus, Carl Zeiss, Göttingen, Germany) equipped with green
and red filters. Photomicrographs were taken at 40-100× magnification. For confirmation of
colocalization of CTB and 5HT, we combined red and green color channels using Adobe
Photoshop (Adobe Systems, San Jose, CA, USA). The number of cells labeled for 5HT and/
or CTB were counted for the whole DR per section. Here, we report the average of those
counts for all levels of the mDR combined.
3. Results
3.1. Experiment 1: Neural activation in TMM, SUM and raphe
In the raphe nuclei, the total number of 5HT-positive cells did not differ significantly as a
function of time of day in any region (all p values > 0.21). Data on serotonergic cells
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expressing Fos in the lDR, and mDR3 were not analyzed because double-labeled cells were
extremely rare in those regions at all times of day. In these two regions, Fos expression in
non-serotonergic cells was also not significantly affected by ZT (lDR: Χ2 = 9.93, df = 5, p =
0.08; and mDR3: Χ2 = 8.17, df = 5, p = 0.15).
In the mDR4, day-night differences in Fos expression were evident in serotonergic cells (Χ2
= 16.45, df = 5, p < 0.01; Fig. 2A) as well as in non-serotonergic cells (Χ2 = 20.61, df = 5, p
< 0.01; Fig. 2B). Pair-wise comparisons revealed similar patterns of Fos expression in
serotonergic and non-serotonergic cells, with the lowest levels occurring between ZT 18 and
ZT 22 (Fig. 2A and 2B). In contrast to the mDR4, in the mDR5 a significant day-night
difference in Fos expression was seen only in serotonergic cells (Χ2 = 15.25, df = 5, p <
0.01; Fig. 2C and 3), but not in non-serotonergic cells (Χ2 = 10.29, df = 5, p = 0.07; Fig. 2D
and 3). The pattern of Fos expression observed in serotonergic cells of the mDR5 was
similar to that seen in the mDR4, with the lowest levels of Fos expression seen between ZT
18 and ZT 22 (Fig. 2C and 3). Finally, in the MR serotonergic cells did not show a day-night
differences in Fos expression (Χ2 = 9.01, df = 5, p = 0.11; Fig. 2E), but non-serotonergic
cells did (Χ2 = 13.32, df = 5, p = 0.02; Fig. 2F), with the lowest levels occurring at ZT 18
and ZT 22 (Fig. 2F).
In the VTM, DTM, and SUM there was a significant effect of time on the expression of Fos
(Χ2 = 15.56, df = 5, p < 0.01; Χ2 = 19.46, df = 5, p < 0.01; and Χ2 = 19.77, df = 5, p < 0.01,
respectively). In these areas, as seen in some of the areas described above, the lowest levels
of Fos expression occurred between ZT 18 and ZT 22 (Fig. 4).
3.2. Experiment 2: Putative projections to the CSF
3.2.1. Retrograde tracing—Ten grass rats received injections that included the 3V and/
or surrounding hypothalamic areas and 6 received injections that included the LV and/or the
dorsal part of the lateral septal nucleus (LSd). Of these cases, one grass rat had an injection
site that was centered in the ventricular system, specifically in the 3V (Fig. 5). In the cases
in which the injection sites extended from the 3V into the periventricular hypothalamic
region (8 cases), the pattern of labeled cells and processes was similar to that produced by
the injection restricted to the 3V including intense labeling in the DR (see below), but in
addition, cellular labeling was present throughout the hypothalamus, lateral septum, and
amygdala (data not shown). Injections that extended from the LV to the caudal LSd (5
cases) also produced intense cellular labeling in the DR, but in addition cellular labeling was
found in the medial septum, vertical and horizontal diagonal bands of Broca, amygdala,
hippocampus, thalamus and hypothalamus (data not shown). In contrast, when the injection
site included neither the 3V (only periventricular areas; 1 case), nor the LV (only the caudal
LSd; 1 case, or cingulate cortex; 1 case), the cluster of CTB-labeled cells seen in the DR of
all the other cases as well as the intense labeling of the surrounding ependyma were absent
(Fig. 6A and 6B). The description that follows is based on the case restricted to the 3V (Fig.
5).
The injection of CTB restricted to the 3V (Fig. 5) produced intense labeling in the
ependymal cell layer surrounding the lateral ventricles, 3V, cerebral aqueduct, and 4V. A
dense cluster of labeled cells was observed in the caudal DR, specifically in the mDR3, and
throughout the mDR4 and mDR5 (Fig. 6A). These labeled cells appeared first in the ventral
part of the mDR3, and more caudally their distribution expanded into the dorsal part of the
DR. Labeled processes that appeared to belong to these cells were observable clearly
approaching the ependymal cell layer of the cerebral aqueduct and 4V (Fig. 6A). In contrast
to the DR, only a few scattered labeled cells were present in the MR. Outside of the raphe
nuclei there was intense labeling of tanycytes in the median eminence (ME; Fig. 6D) and
scattered cell labeling in the hypothalamus, including the suprachiasmatic nucleus (SCN;
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Fig. 6C), ventral subparaventricular zone (vSPZ; Fig. 6C), ME (Fig. 6D), paraventricular
nucleus of the hypothalamus (PVN; Fig. 6E), and the DTM (Fig. 6F).
3.2.2. CTB and 5HT double-labeling—According to our retrograde tracing results, the
periventricular nucleus of the hypothalamus is not likely to receive afferent projections from
the DR since an injection in this region that missed the 3V did not produce CTB positive
cells in the DR (see previous subsection). Therefore, to analyze CTB and 5HT double-
labeling we not only used the case in which the injection was restricted to the 3V, but also
one case in which the injection site extended from the 3V into the periventricular nucleus of
the hypothalamus. In both cases, the distribution and abundance of CTB positive cells was
similar in brain sections processed for light and fluorescent microscopy (Fig. 6A and Fig.
7C), with the rostro-caudal gradient of CTB positive cells extending from the caudal mDR3
to the end of the mDR5. Additionally, the number of double labeled cells (i.e., positive for
both 5HT and CTB), was similar in the two cases. Between 67 to 80% of the retrogradelly
labeled cells of the caudal mDR were immunopositive for 5HT, and between 25 to 30% of
serotonergic cells were also immunopositive for CTB (Fig. 7B).
4. Discussion
4.1. Fos expression in the DR and MR
In nocturnal animals the release of 5HT from the raphe into its target areas, including the
SCN, is increased during the active phase (Barassin et al., 2002), as is the case in the
Sudanese grass rat, Arvicanthis ansorgei, a diurnal rodent closely related to our grass rat
(Cuesta et al., 2008). Thus, the time of day at which the release occurs is reversed when
diurnal and nocturnal rodents are compared. In our grass rats, we observed increased Fos
expression during the active phase within serotonergic cells in some regions of the raphe but
not others. Specifically, whereas 5HT cells in the caudal mDR showed a day-night
difference in Fos expression, cells in the lDR, MR, and rostral areas of the MR did not.
Since the pattern of Fos expression identified in the caudal mDR of our grass rat
corresponds to the temporal pattern of 5HT release in the SCN of the diurnal Sudanese grass
rat (Cuesta et al., 2008), it is likely that the circadian release of 5HT onto target areas
including the grass rat SCN is mediated by terminals emanating from cells in the caudal
mDR. Topographic differences in Fos expression within the DR have also been identified in
the crepuscular Mongolian gerbil, with Fos expression increasing during the transitions
between lights on and off only in the caudal mDR; but the pattern is evident only in non-
serotonergic cells (Janusonis and Fite, 2001). It remains to be determined whether these
differences reflect underlying species differences or differences in their lifestyle habits.
Additional evidence for functional differences in subdivisions of the DR comes from studies
in which animals are exposed to stressful stimuli. For example, sleep deprivation induced by
physical restraint in Syrian hamsters (Webb et al., 2010), and inescapable tail shock in rats
(Grahn et al., 1999) elicit Fos expression selectively in serotonergic cells of the caudal DR.
In contrast, social defeat paradigms in Syrian hamsters induce Fos expression in
serotonergic as well as non-serotonergic cells in only the rostral DR (Cooper et al., 2009).
In addition to its role in promoting wakefulness, 5HT is involved in a variety of behavioral
and physiological functions including aggression, sexual behavior, thermoregulation,
dynamics of the CSF (Hung et al., 1993), and circadian rhythmicity (reviewed in Yannielli
and Harrington, 2004), among others. Its latter role is of particular interest given that in
nocturnal rodents, it modulates circadian responses to non-photic stimuli (i.e., phase shifts
only during the subjective day; reviewed in Yannielli and Harrington, 2004), such as phase
shifts of activity rhythms produced by social interactions or handling. Specifically, the DR
and MR appear to mediate these effects via direct synaptic inputs to the SCN (Meyer-
Bernstein and Morin, 1999). The non-photic phase shifts seen in nocturnal animals are in
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sharp contrast to the ones observed in the diurnal Sudanese grass rat. In this rodent, the
effects of 5HT on the phase of activity rhythms are seen only during the subjective night
(Cuesta et al., 2008). Thus, in diurnal and nocturnal species the effects of 5HT on the
circadian pacemaker appear to be restricted to the rest phase of the species (Challet, 2007).
The implications of these observations are important for understanding the differential role
of 5HT in the circadian regulation of behavior in diurnal and nocturnal species.
We also observed a day-night difference in Fos expression in non-serotonergic cells that
were restricted to some subpopulations of the raphe, namely the mDR4 and MR. Future
work needs to investigate the chemical phenotype of these groups as non-serotonergic
neurons from the DR and MR appear to directly interact with brain regions involved in
important physiological and behavioral functions. For example, GABAergic neurons of the
DR project to the prefrontal cortex, lateral hypothalamus, and nucleus accumbens; areas
involved not only on physiological functions but also on cognition (Bang and Commons,
2012). Also, glutamatergic cells of the MR project to the hippocampus, an area involved in
learning, memory and emotional regulation, and have been implicated in the regulation of
hippocampal neural activity (Jackson et al., 2009). Thus, the day-night profile of Fos
expression seen in non-serotonergic cells of the mDR4 and MR could be related to the roles
that these brain areas have in the modulation of diverse brain processes throughout the sleep/
wake cycle.
4.2. Fos expression in the TMM and SUM
The TMM of several nocturnal species contains dense clusters of histaminergic neurons
which show peak firing during wakefulness (Takahashi et al., 2006), as well as increase Fos
expression at that time (Ko et al., 2003). Unfortunately, due to technical difficulties with the
double-label ICC, in this study we could not determine specifically whether histaminergic
cells of the TMM showed Fos expression patterns. We, however, were able to identify day-
night difference in Fos expression in the VTM and DTM, with higher Fos production during
the day than during the night. This pattern is similar to one reported earlier (Novak et al.,
2000), although with only four sampling times, the previous study missed detecting a
significant effect of time on Fos expression in the DTM. Of note, both the DTM and VTM
of grass rats show a circadian pattern in the expression of the clock protein Per 1 (Nunez et
al., 2012) suggesting that these areas may participate in the regulation of circadian
rhythmicity in grass rats.
The SUM contains a variety of neuronal phenotypes, including neurons immunoreactive for
dopamine, calretinin, substance P, vaso-intestinal peptide (reviewed in Pan and
McNaughton, 2004), as well as for GABA and glutamate related markers (Soussi et al.,
2010); these neurons project to brain areas that regulate behavioral state. In fact, the SUM,
like the MR, plays a role in the modulation of the hippocampal theta wave, through indirect,
as well as direct projections to the hippocampus (reviewed in Pan and McNaughton, 2004).
In addition, the SUM plays a role in reward. Administration of excitatory glutamatergic
agonists to the SUM induces conditioned place preference (Ikemoto et al., 2004), and
exposure to rewarding stimuli elicits neural activation in this area (e.g., Marcangione and
Rompre, 2008). Then, given that the SUM not only plays a role in the regulation of vigilance
states, but also in reward, we expected to find a day-night difference in neural activity in this
area. Our data confirmed that expectation; neurons of the SUM displayed a day-night profile
in Fos expression, with the highest values in the transitions between lights on and off, and
the lowest values in the mid-day and night. This Fos pattern is similar to the locomotor
activity patterns that grass rats show in the laboratory under a 12:12 light-dark cycle
(McElhinny et al., 1997). This concordance is interesting given that in lab rats chemical
stimulation of this nucleus not only increases Fos expression in the SUM but also appears to
facilitate locomotor activity (Shin and Ikemoto, 2010). Future work is needed to address the
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possibility that neural activity in the SUM could influence daily patterns of spontaneous
locomotor activity in our grass rats.
4.3. Putative projections to the CSF
The CSF carries myriad molecules, including 5HT and HA, through the nervous system. In
addition to playing a role in the promotion of wakefulness and in regulation of circadian
rhythmicity, 5HT and HA have been linked to some behavioral disorders. For example, HA
metabolites in the CSF are higher in schizophrenics than in healthy individuals (Prell et al.,
1995), and in patients with major depression and a history of attempts to commit suicide
5HT in the CSF is lower than in non-suicidal patients (Hou et al., 2006). These phenomena
are intriguing given that HA and 5HT are known to influence metabolism of the CP (Hung
et al., 1993, Watson et al., 1995), where CSF is produced. The route by which these two
neurotransmitters reach the CSF has not been definitively established but some evidence in
the lab rat suggests that it is through direct release into the ventricles (5HT: Lorez and
Richards, 1973, Chan-Palay, 1976, HA: Ericson et al., 1987). An additional source of 5HT
and HA could be mast cells. This possibility remains to be tested, as these cells are known to
synthesize both neurotransmitters (Hough, 1988, Kushnir-Sukhov et al., 2007) and to be
located in the CP (Dropp, 1976). In this study, we addressed whether neurons of the raphe
and TMM could release their contents rhythmically into the CSF. To this aim we determined
if CTB injected into the 3V and LV of grass rats would result in the retrograde labeling of
neurons in regions of the brain known to not only contain histaminergic and serotonergic
cell bodies, but also to display day-night differences in neural activity.
Taken together, our results from the case in which the injection site was restricted to the
ventricular system in addition to the cases in which this system was partially included or
missed, helped us corroborate the pattern of projections to the CSF. It is noteworthy that
injections that hit the ventricular system at different sites in the rostro-caudal axis (i.e., LV
and 3V) revealed a rather similar pattern of retrograde labeling. We found that after the
injections to both the 3V and LV, the caudal mDR showed strong cell labeling whereas the
TMM showed scarce cellular labeling restricted to the DTM. Furthermore, labeled fibers in
the mDR and DTM were seen in close proximity to the 3V, which suggests that these cells
could release their content directly into the CSF. These findings are in agreement with
observations made in nocturnal lab rats (Mikkelsen et al., 1997, Simpson et al., 1998). In
addition, injections to the 3V and LV produced cell labeling in the SCN. This pattern of
staining is interesting given that diffusible signals released from this nucleus have been
proposed to control circadian rhythms in locomotor activity (Schwartz and Reppert, 1985,
Lehman et al., 1987, Silver et al., 1996). Our results suggest that a potential route for this
control is a direct one from the SCN to the CSF. We also observed a few labeled cells in the
vSPZ, an area that appears to participate in circadian rhythmicity in the grass rat and in
nocturnal rodents (Lu et al., 2001, Schwartz et al., 2009). Perhaps some of these cells in the
vSPZ influence rhythms via release of signals into the CSF.
The majority of the retrogradely labeled neurons seen in the caudal DR were serotonergic.
We found that approximately two thirds of the CTB labeled cells of the DR were positive
for 5HT; a similar pattern has been identified in the nocturnal lab rat (Mikkelsen et al.,
1997). Interestingly, the double-labeled cells identified in this study were found in the same
areas where we detected a day-night difference in Fos expression in serotonergic cells.
These observations hint that 5HT from the caudal DR may be released into the CSF in a
rhythmic fashion. This is a likely scenario as putative serotonergic axons from the raphe
have been identified in the supra-ependymal plexuses of all ventricles (Aghajanian and
Gallager, 1975). Also, 5HT concentrations in the LV show a pattern of release that covaries
with the ultradian bouts of REM and non-REM sleep (Zeitzer et al., 2002), sleep stages
which are known to be modulated by 5HT neurons of the raphe. Serotonin, once in the CSF,
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could control CP functioning by acting on the CP serotonergic receptors located proximally
or downstream of the release site. In the TMM and DR, we also observed retrogradely
labeled cells of unknown chemical phenotype. Further work needs to address this question,
especially because if these retrogradely labeled cells also show daily patterns of activation
(as seen in the TMM and mDR4), they may be releasing their contents into the CSF in a
rhythmic fashion.
4.4. Conclusions
In summary, this study shows that wake-promoting areas of a diurnal species display a
reversal in neural activation when compared to nocturnal species. Given that the grass rat is
a model used to study the effects of nocturnal shift work (Castillo-Ruiz et al., 2010,
Ramanathan et al., 2010), our findings are informative as they provide normative, baseline
information on Fos expression patterns in wake-promoting areas in this species. Together
with previous work done in the wake-promoting orexinergic system of the grass rat
(Martinez et al., 2002), our results provide further evidence that the evolution of diurnality
required a complete reversal in the functioning of wake-promoting systems. It is likely that
the increase in Fos expression in the raphe and TMM areas is associated with increased HA
and 5HT release at synaptic terminals, as is the case for the wake-promoting system of the
cholinergic basal forebrain (Greco et al., 1999, Greco et al., 2000). Therefore, the maximal
effects of HA and 5HT in target areas, including the main pacemaker of the SCN, are likely
to be seen during the active phase. The effects that the 5HT and HA may have on SCN
functioning is a subject that warrants further investigation in diurnal species. Our anatomical
results also indicate that chemical signals from the SCN and the vSPZ could be released
directly into the CSF. This avenue for the control of circadian rhythms has been proposed
before for nocturnal species (Schwartz and Reppert, 1985, Lehman et al., 1987, Silver et al.,
1996). Our study is the first to provide evidence for that hypothesis in a diurnal mammal.
Finally, our results may suggest that the release of 5HT from the raphe into the CSF may be
involved in circadian control of various functions throughout the nervous system, which
could include the production of CSF itself. Understanding of the functional complexity of
the raphe nuclei is important, since changes in the physiology of this nucleus have been
linked to severe human mental health problems including suicide (Boldrini et al., 2008).
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CTB cholera toxin subunit beta
DR dorsal raphe
DTM dorsal tuberomammillary nucleus
HA histamine
ICC immunocytochemistry
lDR lateral dorsal raphe
LSd lateral septal nucleus, dorsal part
LV lateral ventricle
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mDR3-5 medial dorsal raphe levels 3 through 5
ME median eminence
MR median raphe
NDS normal donkey serum
NGS normal goat serum
PB phosphate buffer
PBS phosphate buffered saline
PLP paraformaldehyde-lysine-sodium periodate
PVN paraventricular nucleus of the hypothalamus
SCN suprachiasmatic nucleus
SUM supramammillary nucleus
TBS tris buffered saline
TMM tuberomammillary nucleus
TX triton-X
vSPZ ventral subparaventricular zone
VTM ventral tuberomammillary nucleus
ZT zeitgeber time
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Fos expression in brain sleep/wake areas predict a species temporal activity pattern
Serotonergic neurons show daily rhythms of Fos expression in the diurnal grass rat Fos
expression in the grass rat suprammamillary nucleus peaks at dusk and dawn Neurons of
the grass rat tuberomammillary nuclei show rhythmic Fos expression Rhythmic
serotonergic neurons of grass rats may have access to the ventricular system
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Rostro-caudal illustrations and corresponding representative photomicrographs depicting the
sampling regions used to quantify Fos expression in serotonergic and non-serotonergic cells
of the lDR, MR, mDR3 (A, B), mDR4 (C, D), and mDR5 (E, F). See text for sampling box
dimensions. Abbreviations: lDR, lateral dorsal raphe; mDR3-mDR5, medial dorsal raphe
levels 3 through 5; MR, median raphe.
Castillo-Ruiz et al. Page 16














Fos expression (mean ± SEM) in serotonergic cells (A, C, and E) and non-serotonergic cells
(B, D, and F) of the mDR4 (A and B), mDR5 (C and D), and MR (E and F) at six different
zeitgeber times (white bars: light phase; grey bars: dark phase). Note that group means with
different letters are significantly different from each other, here as well as in Figure 4.
Abbreviations: 5HT-ir, serotonin like immunoreactive; mDR4-mDR5, medial dorsal raphe
levels 4 and 5; MR, median raphe.
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Photomicrographs of serotonergic cells expressing Fos in the mDR5 at ZT 10 (A) and ZT 22
(B). Arrowheads indicate some double-labeled cells. Fos: blue nuclear staining. 5HT: brown
cell body staining. Abbreviations: 4V, fourth ventricle; mDR5, medial dorsal raphe level 5;
ZT, zeitgeber time.
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Fos expression (mean ± SEM) in the VTM (A), DTM (B), and SUM (C) at six different
zeitgeber times (white bars: light phase; grey bars: dark phase). Abbreviations: DTM, dorsal
tuberomammillary nucleus; Fos-ir, Fos like immunoreactive; SUM, supramammillary
nucleus; VTM, ventral tuberomammillary nucleus.
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Rostro-caudal photomicrographs of the CTB injection site in the 3V (A-E). Abbreviations:
3V, third ventricle; CTB, cholera toxin subunit beta; EC, ependymal cell layer; OX, optic
chiasm; RCh, retrochiasmatic area.
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Photomicrographs of areas that contained CTB-labeled cells after CTB injections to the
ventricular system. Note the dense cell labeling in the mDR5 after injections to the
ventricular system (A) in comparison to an injection that missed it (B). In addition, an
injection restricted to the 3V produced scattered cell labeling in the SCN and vSPZ [C, the
arrow indicates a CTB-positive bipolar neuron magnified in the inset (upper right corner)],
Arc (D), PVN (E), and DTM (F). Arrowheads indicate some CTB-labeled cells.
Abbreviations: 3V, third ventricle; 4V, fourth ventricle; Arc, arcuate nucleus; CTB, cholera
toxin subunit beta; DTM, dorsal tuberomammillary nucleus; mDR5, medial dorsal raphe
level 5; ME, median eminence; OX, optic chiasm; PVN, paraventricular nucleus of the
hypothalamus; SCN, suprachiasmatic nucleus of the hypothalamus; vSPZ, ventral
subparaventricular zone.
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Photomicrographs depicting cells in the mDR5 after staining with Cy2 labeled 5HT (A,
green fluorescence) and Cy3 labeled CTB (C, red fluorescence) in a representative animal
that received a CTB injection directed to the 3V. Panel B is a composite image showing both
labels. White asterisks indicate some double-labeled cells. Abbreviations: 4V, fourth
ventricle; CTB, cholera toxin subunit beta; mDR5, medial dorsal raphe level 5.
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